Mandate

Vinge advises EQT in connection with sale of TitanX

Vinge advises EQT Opportunity and Fouriertransform AB and other sellers in connection with the sale of TitanX Engine Cooling (“TitanX”) to Tata AutoComp Systems Ltd (“Tata”), one of India’s leading auto-component conglomerates. TitanX is a global supplier of powertrain cooling solutions for commercial vehicles and the company serves most of the western world’s OEMs, including Volvo Trucks, Scania, Daimler and Iveco. TitanX has a yearly turnover of SEK 1.6 billion and manufacturers in Sweden, USA, Mexico, Brazil and China.

Subject to customary regulatory approvals, the transaction is expected to be completed during the fall of 2016.

Vinge’s team has primarily consisted of Christina Kokko, Sofie Bjärtun and Samra Baytar (M&A), Fredrik Gustafsson and Karin Isacsson (employment), Thomas Sjöberg and Matilda Gustafsson (environmental), Louise Brorsson and Helena Håkansson (finance) and Pernilla Warg (projectassistant). 

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026